Clinical Trials Logo

Clinical Trial Summary

Oseltamivir dosing in infants < 3 months of age is based on a single pharmacokinetic study in 20 infants from a single center. This dataset is limited by a lack of robustness, because only 1 sample was collected from each participant. The investigators obtained two blood samples each from infants receiving oseltamivir after obtaining informed consent from the infant's parents. The investigators propose to analyze the blood samples to determine the amount of oseltamivir in the infant's blood. Measurement of these values will increase the understanding of the absorption and elimination of oseltamivir in preterm and term infants, and improve our ability to provide the correct doses to this high risk population.


Clinical Trial Description

n/a


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01388439
Study type Observational
Source St. Louis Children's Hospital
Contact
Status Completed
Phase N/A
Start date January 2011
Completion date January 2011

See also
  Status Clinical Trial Phase
Active, not recruiting NCT01493063 - LACTACOL 01 - Impact of Breast Milk on the Neurodevelopment of Preterm Newborns
Completed NCT00817921 - Effect of Prematurity on Renal Function in 5 Years Old Children N/A
Not yet recruiting NCT01305720 - The Effect of Mydriatic Eye Drops on Cerebral and Mesenteric Oxygenation in Preterm Infants Phase 4
Completed NCT01300130 - Investigations on Improving Docosahexaenoic and Arachidonic Acid Content in Preterm Infant Formula N/A
Active, not recruiting NCT01517828 - Intranasal Midazolam Versus Intranasal Ketamine to Sedate Newborns for Intubation in Delivery Room Phase 3
Completed NCT01428180 - Influence of Treatment for Patent Ductus Arteriosus on Cerebral Oxygenation in Preterm Infants Phase 4
Completed NCT01367015 - Early Versus Late Initiation of Feeding in Premature Growth Restricted Newborns With Absent or Reversed End Diastolic Flow On Umbilical Artery Doppler (AREDF) N/A